G-CSF during large field radiotherapy reduces bone marrow recovery capacity

European Journal of Medical Research

Volumn 11, Issue 8, 2006, Pages 322-328

  Pape, Hildergard ^a   Orth, K ^b   Heese, A ^a   Heyll, A ^c   Kobbe, G ^a   Schmitt, G ^a   Niederbichler, A D ^d   Peiper, M ^a   Schwarz, A ^e   Boelke, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Medizinische Klinik II   (Germany)

^c Cancer Center   (Germany)

^d UNIVERSITY OF MICHIGAN   (United States)

^e KH Lindau ^*  (Germany)

Author keywords

CD34; Chemotherapy; Granulocyte colony stimulating factor; Granulocytopenia; Myelopoiesis; Radiotherapy; Stem cell pool capacity; Thrombocytopenia

Indexed keywords

BLEOMYCIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE; VINCRISTINE SULFATE;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD SMEAR; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRANULOCYTE; GRANULOCYTOPENIA; HODGKIN DISEASE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; LUNG SMALL CELL CANCER; LYMPHOCYTOPENIA; MALE; NONHODGKIN LYMPHOMA; RANDOMIZED CONTROLLED TRIAL; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BASOPHILS; BONE MARROW CELLS; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, RADIATION; EOSINOPHILS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HODGKIN DISEASE; HUMANS; LEUKOCYTE COUNT; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEUTROPHILS; PROSPECTIVE STUDIES; TIME FACTORS; WHOLE-BODY IRRADIATION; X-RAYS;

EID: 33748694932     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Zhang HL. Stimulation of low dose radiation on hematopoietic system. Chung Hua I Hsueh Tsa Chih 1993; 73: 99-100, 127
2. Fushiki M, Ono K, Sasai K, Shibamoto Y, Tsutsui K, Nishida T, Takahashi M, Abe M. Effect of recombinant human granulocyte colony-stimulating factor on granulocytopenia in mice induced by irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1990; 18: 353-7
3. Schuening FG, Storb R, Goehle S et al. Effect of recombinant human granulocyte colony stimulating factor on hematopoiesis of normal dose and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 1989; 74: 1308-1313
4. Uckun FM, Souza L, Waddick KG, Wick M and Song CW. In vivo radioprotective effects of recombinant human granulocyte colony stimulating factor in lethally irradiated mice. Blood 1990; 75: 638-645
5. Macvittie TJ, Monroy RL, Patchen ML et al. Therapeutic use of recombinant human G-CSF ( rhG-CSF) in a canine model of sublethal and lethal whole - body irradiation. Int. J. Radiat. Biol. 1990; 57: 723-36
6. Tanikawa S, Nakao I, Tsuneoka K, Nara N.Effects of recombinant Granulocyte-Colony-Stimulating Factor( rG-CSF) and recombinant Granulocyte-Macrophage-colony-Stimulating Factor (rGM-CSF) on acute radiation hematopoietic injury in mice. Exp. Hematol. 1989; 17: 883-888
7. Patchen ML, Mac Vittie TH J, Solberg BD, Souza LM: Therapeutic administration of recombinant human Granulocyte Colony-Stimulating Factors accelerates hemopoietic regeneration and enhances survival in murine model of radiation-induced myelosuppression. Int. J. Cell. Clon. 1990; 8: 107-122
8. Hosoi Y, Kurishitta A, Ono T, Sakamoto K. Effect of recombinant human Granulocyte Colony-Stimulating Factor on survival in lethally irradiated mice. Acta Oncol. 1992; 31: 59-63
9. Neta R, Douches SD, Oppenheim JJ. Interleukin-1 is a radioprotector. J. Immunol. 1986; 136: 2483-2485
10. Neta R. Radioprotection and therapy of radiation injury with cytokines. In: The Biology of Hematopoesis Wiley-Liss Inc. 1990; pp 471-478
11. Bamberg M, Schmidberger H, Hess C. F. G-CSF in the management of neutropenia during radiotherapy. Tumordiagn. u. Ther. 1992; 13: 125-6
12. Schmidberger H, Hess CF, Hoffmann W, Reuss-Borst MA, Bamberg M. Granulocyte colony - stimulating factor treatment of leucopenia during fractionated radiotherapy. Eur. J. Cancer. 1993; 14: 1927-1931
13. Fushiki M, Abe M, Phase III study of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on neutropenia in radiation therapy (Abstract) Rad. Oncol. 1992; 24: 62
14. Bunn PA jr, Crowly J, Hazuka M et al. A randomized study of VP16/ cisplatin/chest RT ±GM-CSF in limited stage small cell lung cancer: preliminary results of a SWOG study. Lung Cancer 1991; 7 (supp) : 139
15. Bunn PA, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livington R. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective Phase III randomized study of the south west oncology group. J.Clin. Oncol. 1995: 13: 1632-41
16. Momin F, Kraut M, Lattin P et al. Thrombocytopenia in patients receiving chemoradiotherapy and G-CSF for locally advanced non small cell lung cancer (NSCLC). J. Clin. Oncol. 1992, Proc. of ASCO 11: (Abstract 983)
17. Neta R, Oppenheim JJ, Douches SD. Interdependence of the radioprotective effects of human recombinant interleukin1, tumor necrosisfactor, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. 1988; 148: 108-111
18. Neta R, Oppenheim JJ: Cytokines in therapy of radiation injury. Blood 1988; 72: 108-111
19. Popísil M, Hofer M, Netíkova J, Holá J, Znojil V, Vácha J and Vacek A. Pretreatment with Granulocyte Colony-Stimulating Factor reduces myelopoiesis in irradiated mice. Radiat. Res. 1999; 151: 363-367
20. Baird MC, Hendry JH, and Testa NG. Radiosensitivity increases with differentiation status of murine hemopoietic progenitor cells selected using enriched marrow subpopulation and recombinant growth factors. Radiat.Res. 1990; 123: 292-294
21. Uckun FM, Song CW. Radiobiological features of human pluripotent bone marrow progenitor cells (CFU-GEMM). Int. J. Radiat. Oncol. Biol. Phys. 1989; 17: 1021-1025
22. Uckun FM, Gillis S, Souza L, Song W. Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells Int. J. Radiat. Oncol. Biol. Phys.1989; 16: 415-435
23. Dührsen U, Villevall JL, Boyd J et al. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074-2081
24. Schwinger W, Mache C, Urban C, Beaufort F, Toglhofer W.: Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant. 1993;11: 489-492
25. Dreger P, Haferlach T, Eckstein V et al. G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br. J. Haematol. 1994; 87: 609-613
26. Haas R, Murea S. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells. Cytokines Mol. Ther. 1995; 1 (4): 249-270
27. Matsunaga T, Sakamaki S, Kohgo Y et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficients of peripheral blood progenitor cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant. 1993; 11: 103-108
28. Kobbe G. Einflussfaktoren auf die G-CSF-vermittelte Mobilisation hämatopoetischer Progenitorzellen bei Patienten mit hämatologischen Neoplasien und gesunden Stammzellspendern. Dissertation der Medizinischen Fakultät der Heinrich Heine Universirät Düsseldorf. 1999.
29. Nothdurft W, Kreija L. Hemopoietic progenitor cells in the blood as indicator of the functional status of the bone marrow after total body irradiation: experiences from studies in dogs. Stem Cells 1998; 16 ( Suppl.): 97-111
30. Mazur G, Wrobel T, Wlodarska-Polinska I, Lacko A, Bojarowska K, Jagas M, Kuliczkowski K. Assessment of hematopoiesis regeneration in patients with solid tumors after radiotherapy Pol Arch Med Wewn. 2004 Jan;111(1): 53-6
31. Wang TJ, Liu LL, Cheng GH, Liu YL, Qu YQ, Wu ZF, Zhang CF. A brief report-on effect of rhG-CSF in treating leukopenia after radio-and chemo-therapy of patients with breast cancer Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Jun;12(3):381-2
32. Qiu HY, Wu DP, Sun AN, Chang WR, Jin ZM, Miao M, Tang XW, Shen YM, Fu ZZ. Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies Zhonghua Xue Ye Xue Za Zhi. 2004 Aug;25(8):462-5.
33. Movsas B, Hudes RS, Schol J, Mellenson M, Rosvold E, Nicolaou N, Litwin S, Wang H, Keenan E, Curran WJ Jr, Langer CJ. Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim report Clin Lung Cancer. 2001 Nov;3(2):125-32
34. Takeyama K, Ohto H. PBSC mobilization Transfus Apheresis Sci. 2004 Dec;31(3):233-43